CXCR3 Ligands Are Associated with the Continuum of Diffuse Alveolar Damage to Chronic Lung Allograft Dysfunction
- 1 November 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 188 (9) , 1117-1125
Abstract
Rationale: After lung transplantation, insults to the allograft generally result in one of four histopathologic patterns of injury: (1) acute rejection, (2) lymphocytic bronchiolitis, (3) organizing pneumonia, and (4) diffuse alveolar damage (DAD). We hypothesized that DAD, the most severe form of acute lung injury, would lead to the highest risk of chronic lung allograft dysfunction (CLAD) and that a type I immune response would mediate this process. Objectives: Determine whether DAD is associated with CLAD and explore the potential role of CXCR3/ligand biology. Methods: Transbronchial biopsies from all lung transplant recipients were reviewed. The association between the four injury patterns and subsequent outcomes were evaluated using proportional hazards models with time-dependent covariates. Bronchoalveolar lavage (BAL) concentrations of the CXCR3 ligands (CXCL9/MIG, CXCL10/IP10, and CXCL11/ITAC) were compared between allograft injury patterns and “healthy” biopsies using linear mixed-effects models. The effect of these chemokine alterations on CLAD risk was assessed using Cox models with serial BAL measurements as time-dependent covariates. Measurements and Main Results: There were 1,585 biopsies from 441 recipients with 62 episodes of DAD. An episode of DAD was associated with increased risk of CLAD (hazard ratio, 3.0; 95% confidence interval, 1.9–4.7) and death (hazard ratio, 2.3; 95% confidence interval, 1.7–3.0). There were marked elevations in BAL CXCR3 ligand concentrations during DAD. Furthermore, prolonged elevation of these chemokines in serial BAL fluid measurements predicted the development of CLAD. Conclusions: DAD is associated with marked increases in the risk of CLAD and death after lung transplantation. This association may be mediated in part by an aberrant type I immune response involving CXCR3/ligands.Keywords
This publication has 47 references indexed in Scilit:
- Progression pattern of restrictive allograft syndrome after lung transplantationThe Journal of Heart and Lung Transplantation, 2013
- Revisiting the pathologic finding of diffuse alveolar damage after lung transplantationThe Journal of Heart and Lung Transplantation, 2012
- Cumulative Exposure to Gamma Interferon-Dependent Chemokines CXCL9 and CXCL10 Correlates with Worse Outcome After Lung TransplantAmerican Journal of Transplantation, 2012
- The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report—2011The Journal of Heart and Lung Transplantation, 2011
- CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosisEuropean Respiratory Journal, 2009
- Late Primary Graft Dysfunction After Lung Transplantation and Bronchiolitis Obliterans SyndromeAmerican Journal of Transplantation, 2008
- Interstitial Inflammatory Lesions of the Pulmonary Allograft: A Retrospective Analysis of 2697 Transbronchial BiopsiesTransplantation, 2008
- Altered Levels of CC Chemokines During Pulmonary CMV Predict BOS and Mortality Post-Lung TransplantationAmerican Journal of Transplantation, 2008
- Combined CMV Prophylaxis Improves Outcome and Reduces the Risk for Bronchiolitis Obliterans Syndrome (BOS) after Lung TransplantationTransplantation, 2006
- Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.Transplantation, 2002